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Abstract 
 
Rapid technological improvements in radiotherapy delivery results in improved outcomes to 
patients, yet current commercial systems with these technologies on board are costly.  The aim of 
this study was to develop a state-of-the-art cancer radiotherapy system that is economical and 
space efficient fitting with current world demands.  The Nano-X system is a compact design that 
is light weight combining a patient rotation system with a vertical 6 MV fixed beam. In this 
paper, we present the Nano-X system design configuration, an estimate of the system dimensions 
and its potential impact on shielding cost reductions. We provide an assessment of implementing 
such a radiotherapy system clinically, its advantages and disadvantages compared to a compact 40 
conventional gantry rotating linac.  The Nano-X system has several differentiating features from 
current radiotherapy systems, it is [1] compact and therefore can fit into small vaults, [2] light 
weight, [3] engineering efficient, i.e., it rotates a relatively light component and the main 
treatment delivery components are not under rotation (e.g., DMLCs).  All these features can have 
an impact on reducing the costs of the system.  In terms of shielding requirements, leakage 
radiation was found to be the dominant contributor to the Nano-X vault and as such no primary 
shielding was necessary.  For a low leakage design, the Nano-X vault footprint and concrete 
volume required is 17m2 and 35m3 respectively, compared to 54m2 and 102m3 for a conventional 
compact linac vault, resulting in decreased costs in shielding. Key issues to be investigated in 
future work are the possible patient comfort concerns associated with the patient rotation system, 50 
as well as the magnitude of deformation and subsequent adaptation requirements.  
 
3 
Introduction 
Radiotherapy is a cost effective treatment for cancer. However, it has high initial costs associated 
with its establishment, such as the purchase of linear accelerators and the construction of 
specialized shielded rooms (vaults) (1). Numerous reports have emerged on the worldwide lack 
of linear accelerators and the annual rise in cancer incidence will spark a growing crisis (2-4). 
Solutions are required to reduce the cost of systems and vaults without compromising on 
radiotherapy delivery accuracy.  60 
Radiotherapy is moving towards image-guided four-dimensional radiotherapy (4DRT) which 
compensates for anatomic changes during treatment improving treatment delivery accuracy and 
outcomes (5). The requirements of this technology are: [1] real-time intrafraction imaging of 
changes in anatomy using onboard or in-room kV and/or MV imaging systems (6); [2] real-time 
position monitoring/tracking, possibly with the use of implanted markers, to identify any changes 
of anatomy (6); and [3] real-time treatment adaptation to compensate for the real-time changes in 
the anatomy using either beam adaptation systems such as dynamic leaf collimators (DMLC) 
(7,8) and beam gating (9) or couch adaptation systems (10). The development of technologies to 
allow the implementation of adaptive RT in the clinic setting are ongoing (11,12), and recent 
clinical implementation of adaptive RT has been established for prostate cancer (13). 70 
Based on the above requirements, we propose a method of introducing cost savings in the 
design of an advanced technology radiotherapy system and vault. Given the necessity of a 
rotation system in radiotherapy, a more economical approach in terms of engineering is to rotate 
the smallest component, the patient, rather than the gantry (14). The potential costs savings of 
utilizing this design are in its engineering efficiency, compact system design and minimal 
shielding requirements, as it allows the use of a fixed beam linac, we have called the design the 
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Nano-X (Nano = small, X = X-ray). A rotating gantry linac design is heavy, bulky and 
necessitates primary shielding in the ceiling and two side walls (other than the floor). Limiting 
gantry rotation will minimize shielding costs (14). 
Economical conventional rotating gantry linacs presently on the market are the Elekta 80 
Compact (Norcross, GA) and the Varian Unique (Palo Alto, CA), which are single energy 6 MV 
linear accelerators and can fit in relatively small vault footprints with cost savings in the concrete 
volume required.  The recommended and commonly used internal space (excluding shielding) 
requirements for a treatment vault is 6.1 × 6.7 m2 (15,16), however the smallest internal vault 
footprint found in the literature was for a Varian Silhouette linac, 4.9 × 5.8 m2 (17).  
In this study, we describe the design and shielding requirement of the Nano-X linac and its 
potential cost savings compared to a compact conventional linac. The experiences and challenges 
of patient rotation in radiation oncology and neurology are expanded on in the discussion 
section.   
 90 
Materials and Methods 
 
The Nano-X system design criteria 
In the design of an economical cancer radiotherapy facility, a principal aim was to 
decrease the size of the current compact radiotherapy system and vault. In order to do this, we 
applied three a priori criteria: [1] the system design would utilize minimal space and cost 
approaches in hardware engineering and building; [2] the designed system’s delivery should 
match current standards best practice in low energy systems range, i.e., enabling interfraction 
and intrafraction (real-time) imaging using MV and kV imaging systems, respectively, as well as 
delivering intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy 100 
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(VMAT) and [3] the system design should fit with the progress of radiotherapy technology 
development, i.e., enable the delivery of real-time adaptive radiotherapy.  
 
Addressing criteria [1] A compact economical solution 
Patient rotation system: The rationale for a patient rotation system rather than gantry rotation is 
to reduce the vault footprint and cost. To enable radiotherapy, the same functionality of gantry 
rotation and control needs to be considered in the patient rotation system, e.g., angular position, 
rotation speed and acceleration and control of the dose delivered and dose rate. By using the 
same functionality as a rotating gantry and changing the frame of reference, a rotating patient 
system enables IMRT and VMAT delivery. A patient rotation system prototype design with full 110 
rotation (360°) in the superior-inferior axis and translational motion in the superior-inferior 
direction is shown in Figure 1. Further developments could include additional rotational and 
translational degrees of freedom. The patient has whole body support through medical grade 
restraint systems along the couch length. Other immobilizing mechanisms such as vacuum 
cushions could be used.  
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Figure 1: Prototype patient rotation system design with 3600 rotation in the superior-inferior axis and translational 
motion along the superior-inferior axis. The center of rotation is approximately about the patient center of mass.   
 120 
Fixed vertical linac: Using a patient rotation system, the Nano-X system design utilizes a 6 MV 
fixed beam vertical linac. Linear accelerators with varying leakage factors are available. For 
example, the S-band Varian Linatron-M has leakage factor options ranging from standard 10-3 to 
10-6 (Varian Linatron; Varian Medical Systems, Palo Alto, CA). In this study, we investigated 
leakage factors of 10-3, 10-4 and 10-5.  
 
Addressing criteria [2] Designed to deliver current standard of care 
A modern linac needs to offer image guided radiotherapy (IGRT), IMRT and VMAT 
solutions. kV and MV imaging systems are integrated in the Nano-X system design to facilitate 
IGRT. For IMRT and VMAT, by using rotational symmetry of the patient and gantry, as well as 130 
the multileaf collimator, IMRT and VMAT could be delivered.  
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Addressing criteria [3] Real-time adaptation to tumor motion 
In patient rotating systems the issue of accounting for organ deformation will be of 
greater concern as larger degree of motion will be experienced due to the rotation. As a result it 
is important that the Nano-X system is equipped with real-time tumor positioning and motion 
tracking, as well as tumor motion adaptation technologies (18). Tracking technologies dealing 
with real-time motion during treatment are currently being developed. It has previously been 
demonstrated that a single kV x-ray imager integrated with DMLC adaptation can be used to 
track translational tumor motion with 2 mm geometric accuracy for conformal, IMRT and 140 
VMAT IMRT-class treatments (11,19).   
Equipment space requirements 
The minimal internal vault space required for safe clinical operation of the equipment 
was calculated. Equipment not required to be in the room was modeled to be kept outside of the 
vault, including storage. The internal vault space required for the Nano-X system was compared 
to a conventional compact linac system. 
 
Shielding design considerations and total vault footprint 
The shielding requirements for the Nano-X system were calculated using the standard 
framework for primary, scattered and leakage radiation. The barrier transmission was calculated 150 
based on a shielding design goal of 0.05 Gy/year and a workload of 29,000 (Gy/year) which was 
obtained from the average value of 400 Gy/week for 6 MV accelerators (20,21). The occupancy 
factor of 10% was used for the ceiling wall and 100% for all other walls (22). The IEC leakage 
requirements limit leakage factor to 10-3 through the source housing (22). In IMRT treatments, 
the leakage radiation is substantially higher and the IMRT factor can range from two to 10 (22). 
For these calculations, an IMRT factor of 10 and IMRT utilization of 80% was assumed. This 
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resulted in a workload of 254,000 Gy/year in the calculation of the leakage radiation barrier. The 
thickness of the barrier was calculated from tenth-value layers (TVLs) based on 6 MV beam 
energy and ordinary concrete shielding. The linac was modeled at the center of the vault. The 
vault footprint was deduced and compared to a conventional compact rotating gantry linac 160 
system vault footprint for which the same shielding design goals and assumptions were used.  
 
Evaluation of potential cost savings of the Nano-X system 
We examined potential cost savings of the Nano-X system compared to a compact 
conventional system.  
 
Results 
 
The Nano-X system design 
The design prototype and a schematic demonstrating the main functional components of the 170 
Nano-X system are shown in Figure 2. In addressing the three design criteria, the proposed 
Nano-X system utilizes a vertical linac, DMLC for intensity modulation and real-time adaptation 
and kV and MV systems for image guidance. A patient rotation system (Figure 1) is used to 
achieve multiple beam angles and VMAT treatments.  
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Figure 2: (A) Proposed Nano-X prototype design. (B) Schematic of the Nano-X main functional components, 
showing the vertical linac, DMLC for intensity modulation and real-time adaptation, kV source and detector and 
MV detector for image guidance and the patient rotation system for multiple beam angle and VMAT treatments.  
 180 
Equipment space requirements 
An estimate of the internal vault space required for the Nano-X system is 
3(L)×3.7(W)×3(H) m3 where the length of the room would be governed by the couch extension, 
approximately ± 0.5 m, the width of the room by the width of the couch (with imaging systems 
attached) and the height of the room by the whole system height, 2.7 m.  
 
Required shielding and total vault footprint 
The conventional rotating gantry linac requires both primary shielding and secondary 
shielding in the vault, with the primary barriers located in the ceiling and the side walls. In a 
conventional rotating gantry linac vault, the worst case secondary radiation is associated with the 190 
scattered radiation just beyond the primary barriers (15). The secondary barriers were required to 
be 1 m thick. The vault size and shielding for the Nano-X and a conventional compact linac 
system are shown in Figure 3.  
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Figure 3: Vault size and shielding for the Nano-X and a conventional compact linac system. (A) Nano-X vault with 
leakage factor of 10-3. (B) Conventional compact vault with leakage factor of 10-3 (C) Nano-X vault with leakage 
factor of 10-5. (D) Nano-X vault with leakage factor of 10-4. The internal room dimensions and shielding barrier 
thicknesses are shown.  
 
In the Nano-X system configuration, the primary beam direction is towards the floor, 200 
hence only secondary barriers are required in the vault. This assumes that the linac vault is on the 
lowest level of the building which is almost always the case, otherwise floor shielding would be 
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needed.  Unlike in a conventional linac vault, in the Nano-X vault, the leakage radiation is 
dominant over the scattered radiation when using a standard leakage factor linac head. The 
required secondary barrier thickness calculated was 1 m. The leakage radiation was made to be 
below the scattered radiation by the use of a linac head with a lower leakage factor. A leakage 
factor of 10-5 was required to reduce the leakage radiation below the scattered radiation, which 
resulted in the necessity of a secondary barrier of thickness 0.4 m. Conservative estimates of the 
shielding requirements for the vaults are shown in Table 1.  Note that reducing the leakage factor 
for conventional linac systems below 10-3 does not reduce the shielding requirements as the 210 
dominant secondary radiation type is scattered radiation.   
 
Table 1: Comparison of shielding requirements for the Nano-X system and a conventional 
compact linac system. The vault cost estimate assumes $8000 per m2. 
System 
Leakage 
factor 
Primary barrier 
Secondary 
barrier 
Internal 
vault 
dimension 
L × W × H 
m3 
Vault 
footprint 
Concrete 
volume 
Vault cost 
estimate 
Dominant 
secondary 
radiation 
type 
Nano-X 10-3  - 1 m 3 × 3.7 × 3 30 m2 80 m3 $240,000 Leakage  
Nano-X 10-4 - 0.7 m 3 × 3.7 × 3 20 m2 60 m3 $160,000 Leakage  
Nano-X 10-5 - 0.4 m 3 × 3.7 × 3 17 m2 35 m3 $136,000 Scattered  
Conventional 
compact 
linac 
10-3 
Side walls: 1.3 m 
Ceiling: 1.2 m 
1 m 4.9× 5.8 × 3 54 m2 102 m3 $432,000 Scattered 
Conventional 
linac 
10-3 
Side walls: 1.3 m 
Ceiling: 1.2 m 
1 m 6.7 × 6.1 × 3 70 m2 131 m3 $560,000 Scattered  
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The vault footprint of the Nano-X system is 30 m2, which is just over half that of the 
estimated compact conventional linac vault footprint of 54 m2 when using a standard 10-3 
leakage factor as recommended by the IEC (22). Using a machine with a leakage factor of 10-5 
reduced the vault footprint to 17 m2. The concrete volume estimates required in the vault 
construction is 80 m3 for the 10-3 leakage factor and 35 m3 for 10-5 leakage factor for the Nano-X 220 
system compared to 102 m3 for a conventional compact linac. 
 
Cost saving estimates due to Nano-X design configuration 
It is difficult to anticipate future system costs which depend on many factors, such as the 
number of units, place of manufacture, factory set-up costs etc. However, there are many 
similarities in parts to a conventional linac, such as the linac itself, MLC and MV and kV 
imaging systems. Therefore, we would expect the Nano-X to cost approximately the same as a 
conventional linac minus the cost of the approximately 3 ton (23) rotating gantry system plus the 
cost of the patient rotation system (~150kg) and minus any additional savings from manufacture 
or service that would be gained by having the main linac components (linac, MLC and imaging 230 
systems) fixed rather than rotating.  
 
The shielding requirements 
What can be reasonably quantified is the cost of the vault construction, which we 
estimated to be proportional to the amount of concrete required to build, at a rate of $8000 per 
m2. An estimate of the cost of the Nano-X system vault is shown in Table 1. For a standard 
leakage linac head, the Nano-X ($240,000) saves $306,000 over a conventional compact linac 
($432,000). For the Nano-X with a standard leakage factor (10-3), leakage radiation is the 
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dominant factor in the shielding calculations. Further reductions in cost can be made with lower 
leakage systems e.g., only $136,000 is required for a low leakage (10-5) system.  240 
 
Discussion 
Advantages of the Nano-X system 
Approximately 37% of the initial capital required for the establishment of a new radiotherapy 
facility is associated with the cost of the equipment and vault (24).  In this study, we have 
outlined a new radiotherapy treatment machine design concept, the Nano-X system which has 
some advantages and disadvantages for use clinically compared to a conventional system. The 
Nano-X system design combines an advanced light weight compact system and small vault 
(30 m2, Table 1) which can potentially be an economical solution to improving the shortage of 
radiotherapy machines. This system configuration enables cost savings mainly in the shielding.  250 
Our calculations show that the patient rotation system can fit into a vault nearly half the size of 
that needed for a conventional compact rotating gantry system and requires half the amount of 
concrete. The Nano-X system is able to fit into an even smaller vault footprint, 17 m2 and 
requires even less concrete, 35 m3 (Table 1) when using a lower leakage factor linac. An estimate 
of the reduction in shielding costs compared to a conventional compact 6 MV linac is 
approximately $300,000. 
These vault footprint estimates are based on utilizing a shielded door rather than a maze 
in the vault. Whilst the advantage of not using a maze is that the vault footprint can be kept to a 
minimum, this is balanced by the use of a more expensive shielded door (22). A limitation of the 
small vault size is that it does not allow long source-surface distance treatments, such as total 260 
body irradiation and total skin election therapy. 
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In high-income countries, the Nano-X’s compactness could be appropriate in expensive 
or space-constrained metropolitan areas to relieve the stress on centralized centers. In rural areas, 
the economical characteristics of the Nano-X provide a solution to fit with the lower budget per 
population, and potentially allows for mobile treatments similar to the Tomotherapy on a truck 
concept.  
 
Major challenges to overcome 
Though there may be size and cost savings associated with the Nano-X system, there are major 
challenges to overcome, and indeed may render the Nano-X impractical.  These include patient 270 
acceptance of rotation, adaptation technologies to account for patient deformation during 
rotation, coplanar beam delivery, non-isocentric treatments and patient safety which are 
discussed below.   
The highest priority issues to be investigated in future studies are the patient comfort, 
claustrophobia and vertigo concerns associated with the patient rotation system. Motion sickness 
has been reported in studies for fast rotation.  In the Human Disorientation Device, 20 pilots-in-
training were subjected to horizontal rotations of 10 and 30 revolutions-per-minute (rpm). ‘A 
high incidence of sickness’ was observed and 12 of the 20 patients were not able to complete the 
planned study (25). Similar results were found for a later study of 14 subjects at 20 rpm (26).  
These studies were performed with much higher rotation than than needed for radiation therapy, 280 
where the patient rotation of less than 1 rpm would balance patient comfort and treatment 
workflow. There are three reasons to hypothesize that most, or at least some, cancer patients 
would accept slow (<1 rpm) horizontal (roll) rotation: 
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1. Radiotherapy patients accept translation: Three independent groups have studied patient 
comfort for intrafractional translational motion. Sweeney et al. (27) studied 23 patients and 
D’Souza et al. (28) studied 50 patients using a simulated motion pattern. Wilbert et al. (29) 
studied 15 volunteers using correlated and uncorrelated motion. Overall, couch translation 
is well tolerated and motion sickness was not observed. Indeed, Sweeney et al. (27) found, 
“There is, to our knowledge, no sound data on the subject of potential intolerance to robotic 
couch motion.” These works give us evidence that radiotherapy patients accept 290 
translational motion.   
2. Horizontal rotation is used routinely for proton and particle therapy: The Product Genesis 
patient positioning device (30) is in routine use for brain cancer patients at the 
Massachusetts General Hospital Fixed Beam Stereotactic Proton Facility. This device is 
equipped with five degrees of freedom, two partially rotating axes and three linear 
translational axes. The couch typically rotates up to 900 during patient treatments.  7-10 
new patients are treated with this system each week. A single fraction treatment takes ~1 
hour with 5-6 beam angles.  A fractionated treatment takes ~15 minutes with 1-3 beam 
angles.  Additionally, a partial patient rotating system, ±200, at the Heavy Ion Medical 
Accelerator (HIMAC) has been used for carbon ion therapy.  A literature search failed to 300 
find any reported patient comfort or claustrophobia concerns with rotation during 
radiotherapy.   
3. Multi-plane rotation is used routinely in neurology: Outside of radiation oncology, a well-
known patient rotation system is the Vesticon Omniax system which has complex full-body 
maneuvers in all three rotational planes. The Omniax (or other similar device) is commonly 
used to treat benign paroxysmal positioning vertigo (BPPV) which is the most common 
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vestibular disorder in adults, with a lifetime prevalence of 2.4% (31). Sometimes up to 40 
rotations are needed for the treatment of BPPV. A literature search failed to find any 
reported patient comfort or claustrophobia concerns with rotation for the Omniax, 
including a 986 patient study (32).  Can these results be extrapolated to cancer patients? 310 
Although cancer patients are indeed generally in poorer health, and in many cases much 
poorer health than the general public, balance disorder patients are also generally in poorer 
health than the general public.  Additionally, balance disorder patients by definition have 
problems with vertigo.  Finally, the most uncomfortable rotation plane is pitch when then 
legs are higher than the head, causing a dramatic change in the pressure and fluid 
distribution within the body and particularly the brain.  For the Nano-X device, only roll 
rotation is intended for the initial prototype.   
 
Related to the above discussion, there are a number of factors that will determine patient 
eligibility for a Nano-X treatment. For example patient size, medical co-morbidities, 320 
performance status, age and disease site and stage.  There will almost certainly be a subgroup of 
patients who are not eligible for the Nano-X treatment.  If the Nano-X is one of several linacs in 
a facility, then ineligible patients for the Nano-X could be treated on the other linacs.  However 
the proportion of ineligible patients becomes more critical if the Nano-X linac is the sole cancer 
radiotherapy system in a hospital or indeed a geographic region. Careful design of the final 
patient transport and rotation system is needed to maximize both patient comfort and the number 
of cancer sites that can be treated.  
 
 
17 
Organ motion in conventional gantry rotating radiotherapy treatments is a problem 330 
resulting in tumor translation, rotational displacements and deformation (6). In a patient rotating 
system, the issue of organ motion is likely to be more severe as the rotational motion may 
introduce larger tumor motion than would otherwise result from treatment using a conventional 
linac system. This issue would require the incorporation of real-time tumor motion monitoring 
systems. The development of new technologies which take into account real-time tumor 
deformation will be necessary (33). Other than organ deformation arising from rotation, organ 
densities can also change. Lung tissue density has been shown to differ in the prone vs. supine 
position (34). These changes will also need to be taken into account in treatment planning and 
delivery. 
The current Nano-X system, as envisaged in Figure 2, will not allow for non-coplanar 340 
beam delivery.  This limitation is common with the current clinical Tomotherapy systems.  For 
the Tomotherapy system, planning studies have been performed for several sites demonstrating 
that rotation IMRT with co-planar beams gives acceptable plans, and often superior to fixed field 
non-coplanar IMRT (35-37).  Should non-coplanar beams be considered essential, it is possible 
that the Nano-X design could be adjusted to accommodate some degree of non-coplanar 
delivery. However, this would add cost which may negate some of the potential economic 
benefits of the Nano-X system.   
The patient rotation system shown (Figure 1) does not allow for translation in the left-
right or anterior-posterior directions. Therefore, for non-central lesions, such as peripheral lung 
lesions, the planning target volume is separate from the isocenter.  Such a non-isocentric set-up 350 
is common for arc treatments where clearance is an issue. E.g. Ross (38) explain their setup for 
peripheral lung treatments where ‘The isocenter is placed at the lateral midpoint of the table, and 
18 
vertical midpoint of the patient and immobilization device, approximately 14.5 cm above the 
table top to allow the gantry full 360° rotation.’ 
Patient safety issues are also important criteria that need to be addressed in a patient 
rotation system. Couch safety and an emergency release mechanism are essential. Moreover, the 
couch needs to be comfortable for treatment times of up to 30 minutes.  
 
Conclusion 
A compact advanced radiotherapy system design, ‘Nano-X’ has been proposed utilizing a patient 360 
rotating mechanism. This system design has numerous advantages which can substantially 
reduce costs associated in the establishment of a radiotherapy facility. Key issues to be 
investigated are possible patient discomfort, claustrophobia and vertigo concerns associated with 
the patient rotation system. Through government funding, a prototype Nano-X system is 
currently being built in Australia. 
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